The current RGC market cap is 87.06M. The company's latest EPS is USD -0.4512 and P/E is -14.83.
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -391k | -812k | -1.38M | -7.62M | -6.27M |
Net Income | -391k | -812k | -1.35M | -7.6M | -5.87M |
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 243k | 514k | 340k | 18.02M | 12.62M |
Total Liabilities | 2.08M | 3.17M | 4.34M | 938k | 633k |
Total Equity | -1.84M | -2.65M | -4M | 17.08M | 11.99M |
Market Cap | 87.06M |
Price to Earnings Ratio | -14.83 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 55.61 |
Price to Book Ratio | 7.26 |
Dividend Yield | - |
Shares Outstanding | 13.01M |
Average Volume (1 week) | 18.37k |
Average Volume (1 Month) | 217.17k |
52 Week Change | -52.52% |
52 Week High | 32.44 |
52 Week Low | 3.00 |
Spread (Intraday) | 0.52 (7.65%) |
Company Name | Regencell Bioscience Holdings Ltd |
Address |
11/f first commercial building hong kong 999077 |
Website | https://www.regencellbioscience.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.